Literature DB >> 25545641

A 7.5-Mb duplication at chromosome 11q21-11q22.3 is associated with a novel spastic ataxia syndrome.

Janel O Johnson1, Giovanni Stevanin, Joyce van de Leemput, Dena G Hernandez, Sampath Arepalli, Sylvie Forlani, Reza Zonozi, J Raphael Gibbs, Alexis Brice, Alexandra Durr, Andrew B Singleton.   

Abstract

BACKGROUND: The autosomal dominant spinocerebellar ataxias are most commonly caused by nucleotide repeat expansions followed by base-pair changes in functionally important genes. Structural variation has recently been shown to underlie spinocerebellar ataxia types 15 and 20.
METHODS: We applied single-nucleotide polymorphism (SNP) genotyping to determine whether structural variation causes spinocerebellar ataxia in a family from France.
RESULTS: We identified an approximately 7.5-megabasepair duplication on chromosome 11q21-11q22.3 that segregates with disease. This duplication contains an estimated 44 genes. Duplications at this locus were not found in control individuals.
CONCLUSIONS: We have identified a new spastic ataxia syndrome caused by a genomic duplication, which we have denoted as spinocerebellar ataxia type 39. Finding additional families with this phenotype will be important to identify the genetic lesion underlying disease.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  SCA39; genomic duplications; spinocerebellar ataxia; structural variation; whole-genome genotyping

Mesh:

Year:  2014        PMID: 25545641      PMCID: PMC4318767          DOI: 10.1002/mds.26059

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

2.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.

Authors:  Anne Rovelet-Lecrux; Didier Hannequin; Gregory Raux; Nathalie Le Meur; Annie Laquerrière; Anne Vital; Cécile Dumanchin; Sébastien Feuillette; Alexis Brice; Martine Vercelletto; Frédéric Dubas; Thierry Frebourg; Dominique Campion
Journal:  Nat Genet       Date:  2005-12-20       Impact factor: 38.330

3.  Unstable nucleotide repeat minireview series: a molecular biography of unstable repeat disorders.

Authors:  Harry T Orr
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

Review 4.  Genetics of hereditary spastic paraplegias.

Authors:  Rebecca Schüle; Ludger Schöls
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

5.  An evaluation of copy number variation detection tools from whole-exome sequencing data.

Authors:  Renjie Tan; Yadong Wang; Sarah E Kleinstein; Yongzhuang Liu; Xiaolin Zhu; Hongzhe Guo; Qinghua Jiang; Andrew S Allen; Mingfu Zhu
Journal:  Hum Mutat       Date:  2014-05-01       Impact factor: 4.878

6.  Genotype-phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1.

Authors:  J M van de Kamp; A Errami; M Howidi; I Anselm; S Winter; J Phalin-Roque; H Osaka; S J M van Dooren; G M Mancini; S J Steinberg; G S Salomons
Journal:  Clin Genet       Date:  2014-03-06       Impact factor: 4.438

Review 7.  Neuronal migration disorders.

Authors:  Renzo Guerrini; Elena Parrini
Journal:  Neurobiol Dis       Date:  2009-02-23       Impact factor: 5.996

Review 8.  Application of genome-wide single nucleotide polymorphism typing: simple association and beyond.

Authors:  J Raphael Gibbs; Andrew Singleton
Journal:  PLoS Genet       Date:  2006-10-06       Impact factor: 5.917

9.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

10.  Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans.

Authors:  Joyce van de Leemput; Jayanth Chandran; Melanie A Knight; Lynne A Holtzclaw; Sonja Scholz; Mark R Cookson; Henry Houlden; Katrina Gwinn-Hardy; Hon-Chung Fung; Xian Lin; Dena Hernandez; Javier Simon-Sanchez; Nick W Wood; Paola Giunti; Ian Rafferty; John Hardy; Elsdon Storey; R J McKinlay Gardner; Susan M Forrest; Elizabeth M C Fisher; James T Russell; Huaibin Cai; Andrew B Singleton
Journal:  PLoS Genet       Date:  2007-05-16       Impact factor: 5.917

View more
  3 in total

Review 1.  Spinocerebellar ataxias (SCAs) caused by common mutations.

Authors:  Ulrich Müller
Journal:  Neurogenetics       Date:  2021-08-16       Impact factor: 2.660

Review 2.  Molecular cytogenetic characterization of partial trisomy of the long arm of chromosome 11 in a patient with multiple congenital anomalies.

Authors:  Austin Walker; Xianfu Wang; Young Mi Kim; Xianglan Lu; Ashley Taylor; Danielle Demarzo; Shibo Li; Hui Pang
Journal:  Mol Cytogenet       Date:  2022-04-19       Impact factor: 1.904

Review 3.  Spinocerebellar ataxia type 23 (SCA23): a review.

Authors:  Fan Wu; Xu Wang; Xiaohan Li; Huidi Teng; Tao Tian; Jing Bai
Journal:  J Neurol       Date:  2020-11-11       Impact factor: 6.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.